🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wei Shen

Mayo Clinic

ORCID: 0000-0002-3779-0451

Also affiliated with Mayo Clinic in Arizona, Heilongjiang Provincial Hospital, Mayo Clinic in Florida, Ningbo No.6 Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

(2023)10.1158/1078-0432.c.6532509.v1
Top 100%
0DataRank
Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Papers

Driven by 4 papers — median percentile 0. Top paper: “Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials”.

Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials

UNC Libraries(2020)10.17615/03zw-2e52
N/A
0DataRank · unranked
5 citations

Mark E. Boye, Ping Wang, Danjie Zhang, Wei Shen, Joseph G. Ibrahim +1 more

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0203
N/A
0DataRank · unranked
22 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Data from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

(2023)10.1158/1078-0432.c.6532509.v1
Top 100%
0DataRank
Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more

Supplementary Table from Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Figshare(2023)10.1158/1078-0432.22487391.v1
Top 100%
0DataRank
Top 100%0 citations

Lisa R. Susswein, Maegan E. Roberts, Hana Yang, Megan L. Marshall, Susan Hiraki +14 more